Serono successfull competitor to Biogen Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Serono successfull competitor to Biogen

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Alfred W. Post who started this subject	6/9/2002 11:12:52 AM
From: Alfred W. Post	Read Replies (1) of 10

In my opinion the recovery chances for Serono have greatly improved since the company recieved according to the company (WWW.serono.com)from the FDA in March 02 the approval to sell its multiple sclerosis drug Rebif, meaning that they should easily record much greater increases in sales and also in earnings for 2002 than the +15% they predicted prior tp tje FDA ruling without including sales of Rebif. Fred

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next